Pages that link to "Q45722189"

The following pages link to Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion. (Q45722189):

Displaying 40 items.

• A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease (Q21560951) (← links)
• Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine. (Q30382453) (← links)
• Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine (Q30421413) (← links)
• Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge (Q33284583) (← links)
• Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine (Q33359620) (← links)
• Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model (Q34033869) (← links)
• “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era (Q34200918) (← links)
• Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines (Q35049480) (← links)
• Nanoemulsion-based mucosal adjuvant induces apoptosis in human epithelial cells (Q35434746) (← links)
• Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants (Q35593603) (← links)
• Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59. (Q36239573) (← links)
• Modified Nanoemulsions with Iron Oxide for Magnetic Resonance Imaging (Q36320689) (← links)
• A novel, killed-virus nasal vaccinia virus vaccine (Q36452370) (← links)
• Nanoemulsion nasal adjuvant W₈₀5EC induces dendritic cell engulfment of antigen-primed epithelial cells (Q36565552) (← links)
• In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species (Q37032826) (← links)
• Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant (Q37130834) (← links)
• Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats (Q37320191) (← links)
• Nanoemulsion mucosal adjuvant uniquely activates cytokine production by nasal ciliated epithelium and induces dendritic cell trafficking. (Q37594498) (← links)
• Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant. (Q37627725) (← links)
• Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant. (Q37724921) (← links)
• Mucosal and Systemic Immune Responses to Influenza H7N9 Antigen HA1-2 Co-Delivered Intranasally with Flagellin or Polyethyleneimine in Mice and Chickens (Q37737532) (← links)
• Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design (Q37792984) (← links)
• Progress towards a needle-free hepatitis B vaccine (Q37810816) (← links)
• Cancer vaccines. Any future? (Q37885282) (← links)
• Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomolecules (Q38011799) (← links)
• Applications of nanotechnology for immunology (Q38123937) (← links)
• Nasal-nanotechnology: revolution for efficient therapeutics delivery (Q38217878) (← links)
• Receptor-specific delivery of protein antigen to dendritic cells by a nanoemulsion formed using top-down non-covalent click self-assembly (Q39162620) (← links)
• Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009. (Q39882249) (← links)
• Intranasal Immunization of Ferrets with Commercial Trivalent Influenza Vaccines Formulated in a Nanoemulsion-Based Adjuvant (Q42128915) (← links)
• Fourth International Conference: Modern Vaccines/Adjuvants Formulation--Impact on Future Development: May 15-17 2013, CHUV, Lausanne, Switzerland (Q42724005) (← links)
• Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine. (Q44335525) (← links)
• A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice (Q46974867) (← links)
• Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine (Q57022275) (← links)
• Alternative routes of influenza vaccine delivery (Q57114644) (← links)
• The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination (Q64130191) (← links)
• Effective nasal influenza vaccine delivery using chitosan (Q81785770) (← links)
• Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens (Q82481907) (← links)
• Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes (Q90082678) (← links)
• Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge (Q91841779) (← links)